Date published: 2025-11-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr962 Inhibitors

Olr962 inhibitors represent a class of chemical compounds specifically designed to interact with and inhibit the function of the olfactory receptor 962 (Olr962), a protein found within the olfactory system of certain organisms. Olr962 is part of the larger family of G-protein coupled receptors (GPCRs), which play a critical role in signal transduction by converting extracellular signals into intracellular responses. Inhibitors of Olr962 are crafted through various organic synthesis techniques to achieve high specificity and potency. These inhibitors often feature structural motifs that mimic the natural ligands of Olr962, allowing them to competitively bind to the receptor's active site. By preventing the normal binding and activation process, these compounds can effectively modulate the olfactory signaling pathways that Olr962 participates in.

The development and study of Olr962 inhibitors involve intricate processes of chemical design, synthesis, and characterization. Researchers utilize advanced methods such as computer-aided drug design (CADD) to predict the interaction between potential inhibitors and the Olr962 receptor. These computational models are subsequently validated through in vitro and in vivo experiments. Techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are employed to determine the binding affinity and structural conformation of inhibitors when bound to Olr962. Additionally, structure-activity relationship (SAR) studies are conducted to refine the chemical structures, enhancing their efficacy and selectivity. The comprehensive analysis of Olr962 inhibitors not only provides insights into the receptor's function but also advances the broader understanding of GPCR signaling mechanisms. Through these detailed investigations, researchers can explore the fundamental biochemical and molecular dynamics governing olfactory perception and receptor-ligand interactions.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib

152459-95-5sc-267106
sc-267106A
sc-267106B
10 mg
100 mg
1 g
$25.00
$117.00
$209.00
27
(1)

Inhibits BCR-ABL and c-KIT, potentially affecting pathways related to Olr962.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

SRC-family kinase inhibitor, may modulate signaling cascades impacting Olr962.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

EGFR inhibitor, could alter signaling pathways intersecting with Olr962.

Afatinib

439081-18-2sc-364398
sc-364398A
5 mg
10 mg
$112.00
$194.00
13
(2)

Irreversible EGFR inhibitor, potentially influencing pathways associated with Olr962.

Ibrutinib

936563-96-1sc-483194
10 mg
$153.00
5
(0)

BTK inhibitor, may impact signaling networks relevant to Olr962.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$127.00
$178.00
2
(1)

Multi-targeted kinase inhibitor, potentially influencing a range of pathways linked to Olr962.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$112.00
$163.00
$928.00
19
(1)

MEK inhibitor, might affect MAPK/ERK pathways relevant to Olr962.

Dabrafenib

1195765-45-7sc-364477
sc-364477A
sc-364477B
sc-364477C
sc-364477D
5 mg
25 mg
50 mg
100 mg
10 g
$138.00
$255.00
$273.00
$403.00
$12240.00
6
(1)

BRAF inhibitor, could alter signaling cascades intersecting with Olr962.

Everolimus

159351-69-6sc-218452
sc-218452A
5 mg
50 mg
$128.00
$638.00
7
(1)

mTOR inhibitor, may impact cellular processes and pathways related to Olr962.

Ruxolitinib

941678-49-5sc-364729
sc-364729A
sc-364729A-CW
5 mg
25 mg
25 mg
$246.00
$490.00
$536.00
16
(1)

JAK1/2 inhibitor, could modulate signaling pathways relevant to Olr962.